glucagon has been researched along with glucagon (19-29) in 21 studies
| Studies (glucagon) | Trials (glucagon) | Recent Studies (post-2010) (glucagon) | Studies (glucagon (19-29)) | Trials (glucagon (19-29)) | Recent Studies (post-2010) (glucagon (19-29)) |
|---|---|---|---|---|---|
| 26,039 | 1,498 | 3,054 | 21 | 0 | 2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.76) | 18.7374 |
| 1990's | 12 (57.14) | 18.2507 |
| 2000's | 6 (28.57) | 29.6817 |
| 2010's | 2 (9.52) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bataille, D; Blache, P; Brechler, V; Kervran, A; Laurent, S; Le-Nguyen, D; Pavoine, C; Pecker, F | 1 |
| Bataille, D; Brechler, V; Dufour, M; Le-Nguyen, D; Lotersztajn, S; Pavoine, C; Pecker, F; Roche, B | 1 |
| Carrey, EA; Epand, RM | 1 |
| Pavoine, C; Pecker, F; Sauvadet, A | 1 |
| Bataille, D; Blache, P; Kervran, A; Le-Nguyen, D | 1 |
| Bataille, D; Blache, P; Cohen-Solal, A; Duckworth, W; Dufour, M; Kervran, A; Le-Nguyen, D | 1 |
| Ananthanarayanan, VS; Brimble, KS | 1 |
| Pavoine, C; Pecker, F; Rohn, T; Sauvadet, A | 2 |
| Bataille, D; Bergeron, F; Blache, P | 1 |
| Cobbold, PH; Dixon, CJ; Green, AK | 1 |
| Bataille, D; Blache, P; Dalle, S; Le Brigand, L; Le-Nguyen, D | 1 |
| Ashcroft, FM; Bataille, D; Bergeron, F; Blache, P; Dalle, S; Le Brigand, L; Le-Nguyen, D; Smith, P | 1 |
| Barry, L; Bataille, D; Dalle, S; Dufour, M; Fontés, G; Gross, R; Lajoix, AD; LeBrigand, L; LeNguyen, D; Ribes, G | 1 |
| Lefèbvre, PJ | 1 |
| Authier, F; Briand, G; Cameron, PH; Kouach, M; Merlen, C | 1 |
| Abe, S; Aizawa, Y; Chang, H; Elnaggar, R; Hanawa, H; Hayashi, M; Kato, K; Kodama, M; Komura, S; Liu, H; Maruyama, H; Miyazaki, J; Okura, Y; Watanabe, R; Yoshida, T | 1 |
| Bataille, D; Costes, S; Dalle, S; Fontés, G; Longuet, C | 1 |
| Bataille, D; Bergeron, F; Cadel, S; Dalle, S; Fontés, G; Foulon, T; Gross, R; Lajoix, AD; Le-Nguyen, D; Prat, A; Tribillac, F | 1 |
| Bataille, D; Dalle, S | 1 |
| Ferguson, EC | 1 |
5 review(s) available for glucagon and glucagon (19-29)
| Article | Year |
|---|---|
Miniglucagon production from glucagon: an extracellular processing of a hormone used as a prohormone.
Topics: Animals; Cysteine Endopeptidases; Female; Glucagon; Liver; Male; Metalloendopeptidases; Models, Biological; Organ Specificity; Peptide Fragments; Protein Processing, Post-Translational; Rats | 1994 |
Endoprotease regulation of miniglucagon production.
Topics: Amino Acid Sequence; Animals; Endopeptidases; Female; Gastric Mucosa; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Intestine, Small; Islets of Langerhans; Male; Molecular Sequence Data; Muscle, Smooth; Organ Specificity; Peptide Biosynthesis; Peptide Fragments; Peptides; Protein Precursors; Protein Processing, Post-Translational | 1996 |
[Miniglucagon: is the precursor a traitor to its family or a genius? ].
Topics: Amino Acid Sequence; Animals; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Islets of Langerhans; Molecular Sequence Data; Peptide Fragments; Protein Precursors | 2004 |
The forgotten members of the glucagon family.
Topics: Animals; Energy Metabolism; Glicentin; Glucagon; Humans; Multigene Family; Oxyntomodulin; Peptide Fragments | 2014 |
QUESTION 1: Can mini-glucagon be used to manage hypoglycaemia as an outpatient?
Topics: Blood Glucose; Child, Preschool; Diabetes Mellitus, Type 1; Female; Gastroenteritis; Glucagon; Humans; Hypoglycemia; Outpatients; Peptide Fragments | 2016 |
16 other study(ies) available for glucagon and glucagon (19-29)
| Article | Year |
|---|---|
Miniglucagon [glucagon-(19-29)] is a component of the positive inotropic effect of glucagon.
Topics: Animals; Atrial Natriuretic Factor; Cells, Cultured; Chick Embryo; Cyclic AMP; Cyclic GMP; Glucagon; Heart; Heart Ventricles; Isoproterenol; Kinetics; Myocardial Contraction; Peptide Fragments; Ventricular Function | 1991 |
Glucagon-(19-29) exerts a biphasic action on the liver plasma membrane Ca2+ pump which is mediated by G proteins.
Topics: Adenylate Cyclase Toxin; Adenylyl Cyclases; Animals; Calcium; Calcium-Transporting ATPases; Cell Membrane; Cholera Toxin; Female; Glucagon; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Guanosine Triphosphate; Kinetics; Liver; Magnesium; Peptide Fragments; Pertussis Toxin; Rats; Rats, Inbred Strains; Sodium Fluoride; Thionucleotides; Virulence Factors, Bordetella | 1990 |
Conformational and biological properties of glucagon fragments containing residues 1-17 and 19-29.
Topics: Adenylyl Cyclases; Animals; Calorimetry, Differential Scanning; Cattle; Cell Membrane; Circular Dichroism; Cysteine Endopeptidases; Dimyristoylphosphatidylcholine; Endopeptidases; Glucagon; Liver; Peptide Fragments; Protein Conformation; Rats; Receptors, Cell Surface; Receptors, Glucagon; Structure-Activity Relationship; Swine | 1983 |
Inhibition of the sarcolemmal Ca2+ pump in embryonic chick heart cells by mini-glucagon.
Topics: Animals; Calcium; Calcium-Transporting ATPases; Cells, Cultured; Chick Embryo; Glucagon; Ion Transport; Kinetics; Myocardium; Peptide Fragments; Sarcolemma; Vanadates | 1995 |
Endopeptidase from rat liver membranes, which generates miniglucagon from glucagon.
Topics: Amino Acid Sequence; Animals; Blotting, Western; Cattle; Cell Membrane; Chromatography, Gel; Electrophoresis, Polyacrylamide Gel; Endopeptidases; Gastric Mucosa; Glucagon; Kidney; Liver; Molecular Sequence Data; Myocardium; Pancreas; Peptide Fragments; Peptides; Protease Inhibitors; Rats; Swine | 1993 |
Calcium binding and translocation properties of glucagon and its fragments.
Topics: Binding Sites; Calcium; Circular Dichroism; Drug Stability; Glucagon; Kinetics; Liposomes; Magnesium; Peptide Fragments; Protein Binding; Protein Conformation; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Tryptophan; Zinc | 1993 |
Synergistic actions of glucagon and miniglucagon on Ca2+ mobilization in cardiac cells.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Calcium; Calcium Channel Blockers; Calcium Channels; Cells, Cultured; Chick Embryo; Drug Synergism; Glucagon; Heart Ventricles; Isradipine; Peptide Fragments; Sarcoplasmic Reticulum | 1996 |
Arachidonic acid drives mini-glucagon action in cardiac cells.
Topics: 5,8,11,14-Eicosatetraynoic Acid; 8-Bromo Cyclic Adenosine Monophosphate; Animals; Arachidonic Acid; Caffeine; Calcium; Cells, Cultured; Central Nervous System Stimulants; Chick Embryo; Dose-Response Relationship, Drug; Drug Synergism; Electric Stimulation; Glucagon; Homeostasis; Myocardial Contraction; Myocardium; Peptide Fragments; Phospholipases A; Phospholipases A2; Sarcoplasmic Reticulum; Stimulation, Chemical | 1997 |
Effects on the hepatocyte [Ca2+]i oscillator of inhibition of the plasma membrane Ca2+ pump by carboxyeosin or glucagon-(19-29).
Topics: Animals; Calcium; Calcium-Transporting ATPases; Cell Membrane; Cells, Cultured; Eosine Yellowish-(YS); Glucagon; Liver; Male; Peptide Fragments; Rats; Rats, Wistar; Signal Transduction; Thapsigargin | 1997 |
Miniglucagon: a local regulator of islet physiology.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calcium Channels; Calcium Channels, L-Type; Cell Line; Cell Membrane; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose; Glyburide; Homeostasis; Insulin; Insulin Secretion; Islets of Langerhans; Kinetics; Membrane Potentials; Peptide Fragments; Peptides | 1998 |
Miniglucagon (glucagon 19-29), a potent and efficient inhibitor of secretagogue-induced insulin release through a Ca2+ pathway.
Topics: Calcium; Calcium Channels; Cell Line; Cholinergic Agonists; Cyclic AMP; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose; Insulin; Insulin Antagonists; Insulin Secretion; Ion Transport; Islets of Langerhans; Membrane Potentials; Peptide Fragments; Peptides; Pertussis Toxin; Virulence Factors, Bordetella | 1999 |
Miniglucagon (glucagon 19-29): a novel regulator of the pancreatic islet physiology.
Topics: Animals; Fluorescent Antibody Technique; Glucagon; Immune Sera; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Male; Microscopy, Electron; Peptide Fragments; Rats; Rats, Wistar | 2002 |
The intriguing diversity of the glucagon gene products.
Topics: Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Humans; Multigene Family; Peptide Fragments; Peptides; Protein Precursors | 2002 |
Endosomal proteolysis of glucagon at neutral pH generates the bioactive degradation product miniglucagon-(19-29).
Topics: Affinity Labels; Animals; Bacitracin; Endosomes; Furin; Glucagon; Hydrogen-Ion Concentration; Insulysin; Iodine Radioisotopes; Male; Mitochondria; Peptide Fragments; Peptide Hydrolases; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Receptors, Glucagon; Substrate Specificity | 2003 |
A novel method to assay proteins in blood plasma after intravenous injection of plasmid DNA.
Topics: Animals; Blood Glucose; Gene Transfer Techniques; Genetic Therapy; Glucagon; Humans; Immunoassay; Interferon gamma Receptor; Interleukin-8; Male; Peptide Fragments; Plasmids; Proteins; Rats; Receptors, Interferon; Recombinant Fusion Proteins | 2004 |
Miniglucagon (MG)-generating endopeptidase, which processes glucagon into MG, is composed of N-arginine dibasic convertase and aminopeptidase B.
Topics: Aminopeptidases; Animals; Calcium; Cells, Cultured; Cobalt; Endopeptidases; Glucagon; Hypoglycemia; Islets of Langerhans; Metalloendopeptidases; Mice; Peptide Fragments; Phenanthrolines; Protease Inhibitors; Recombinant Proteins; Substrate Specificity; Zinc | 2005 |